When Christine Bray’s metastatic ovarian cancer didn’t respond to conventional treatments, her doctors at Cancer Treatment Centers of America® (CTCA) tried something different. A genomic sequencing test showed two mutations in Bray’s tumor that were targeted with a drug not typically used to treat ovarian cancer. Now researchers are using what they learned from her case to help other cancer patients with the same tumor mutations.
Watch the video to learn more about the promise of precision medicine.
